Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD

Tessa K Novick; Aditya Surapaneni; Jung-Im Shin; Shoshana H Ballew; G Caleb Alexander; Lesley A Inker; Alex R Chang; Morgan E Grams

doi:10.2215/CJN.08530718

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1886-1888. doi: 10.2215/CJN.08530718. Epub 2018 Nov 8.

Authors

Tessa K Novick¹, Aditya Surapaneni², Jung-Im Shin², Shoshana H Ballew^{2

3}, G Caleb Alexander³, Lesley A Inker⁴, Alex R Chang⁵, Morgan E Grams¹

Affiliations

¹ Division of Nephrology, Department of Internal Medicine.
² Welch Center for Prevention, Epidemiology and Clinical Research, and.
³ Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
⁴ Division of Nephrology, Department of Internal Medicine, Tufts Medical Center, Boston, Massachusetts; and.
⁵ Division of Nephrology, Geisinger Health System, Danville, Pennsylvania.

No abstract available

Keywords: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Opioid; Prevalence; Renal Insufficiency, Chronic; chronic kidney disease; chronic pain; pain medications.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Analgesics / therapeutic use*
Analgesics, Opioid / therapeutic use*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Drug Utilization / statistics & numerical data
Female
Gabapentin / therapeutic use*
Humans
Male
Middle Aged
Pain / drug therapy*
Renal Insufficiency, Chronic / complications

Substances

Analgesics
Analgesics, Opioid
Anti-Inflammatory Agents, Non-Steroidal
Gabapentin

Publication types

MeSH terms

Substances

Grants and funding